Centro virtual de coordinación del conocimiento en VIH / Sida: experiencia de gestión del conocimiento en políticas en salud

Knowledge management helps to capture and disseminate existing knowledge, creating new knowledge, communication and collaboration between people who have it. Many organizations in Peru which are committed in the fight against HIV-AIDS have contributed to improving society's response to the epidemic; To do this, they have developed various activities and the way they have learned many lessons. However, these had not been systematized much less shared. Network Knowledge Management (RGC) in HIV-AIDS emerges as a community of practice composed of organizations and governmental and non-governmental seeking systematize their best practices effectively and efficiently achieving a collective learning about the achievements and failures in the topic of interest. These experiences are presented on the platform called "Virtual Knowledge Coordination Centre in HIV-AIDS (HIV CVCC)". The National Institute of Health (NIH) in order to meet one of its priorities and research agenda, results of the Concerted Health and contribute to the national policy of modernization of public administration Plan, assumes responsibility for the joint administration and management Peru AIDS Network RGC and HIV CVCC

Centro virtual de coordinación del conocimiento en VIH / Sida: experiencia de gestión del conocimiento en políticas en salud

Knowledge management helps to capture and disseminate existing knowledge, creating new knowledge, communication and collaboration between people who have it. Many organizations in Peru which are committed in the fight against HIV-AIDS have contributed to improving society's response to the epidemic; To do this, they have developed various activities and the way they have learned many lessons. However, these had not been systematized much less shared. Network Knowledge Management (RGC) in HIV-AIDS emerges as a community of practice composed of organizations and governmental and non-governmental seeking systematize their best practices effectively and efficiently achieving a collective learning about the achievements and failures in the topic of interest. These experiences are presented on the platform called "Virtual Knowledge Coordination Centre in HIV-AIDS (HIV CVCC)". The National Institute of Health (NIH) in order to meet one of its priorities and research agenda, results of the Concerted Health and contribute to the national policy of modernization of public administration Plan, assumes responsibility for the joint administration and management Peru AIDS Network RGC and HIV CVCC

Mapping the human genetic architecture of COVID-19

The genetic make-up of an individual contributes to the susceptibility and response to viral infection. Although environmental, clinical and social factors have a role in the chance of exposure to SARS-CoV-2 and the severity of COVID-191,2, host genetics may also be important. Identifying host-specific genetic factors may reveal biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We formed a global network of researchers to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity. Here we describe the results of three genome-wide association meta-analyses that consist of up to 49,562 patients with COVID-19 from 46 studies across 19 countries. We report 13 genome-wide significant loci that are associated with SARS-CoV-2 infection or severe manifestations of COVID-19. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases3,4,5,6,7. They also represent potentially actionable mechanisms in response to infection. Mendelian randomization analyses support a causal role for smoking and body-mass index for severe COVID-19 although not for type II diabetes. The identification of novel host genetic factors associated with COVID-19 was made possible by the community of human genetics researchers coming together to prioritize the sharing of data, results, resources and analytical frameworks. This working model of international collaboration underscores what is possible for future genetic discoveries in emerging pandemics, or indeed for any complex human disease

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field